{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:27:43Z","timestamp":1760239663022,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>In many countries, community pharmacies provide sexual-health-related services to limit the spread of sexually transmitted infections (STIs), including chlamydia testing. To identify suitable target groups for pharmacy-based chlamydia testing in Switzerland, we aimed to assess chlamydia prevalence, identify risk groups, and delineate screening strategies. We conducted a systematic literature search up to December 2019 in PubMed, EMBASE, and Web of Science, according to the PRISMA guidelines, using as keywords \u201cchlamydia\u201d, \u201cscreening\u201d, and \u201cSwitzerland\u201d. Two researchers screened the title, abstract, and full-text article and assessed the methodological quality. The literature search generated 108 hits, and nine studies were included. Chlamydia prevalence ranged between 0.8 and 12.8%. Most frequently affected were undocumented women undergoing voluntary termination of pregnancy (12.8%, 95% CI: 8.4\u201318.9), HIV-positive men who have sex with men (10.9%, 95% CI: 9.2\u201317.6), and adult offenders (6.5%, 95% CI: 3.2\u20139.0). Systematic screening was suggested for the first two risk groups and women suffering a miscarriage. To conclude, chlamydia infections are prevalent in Switzerland, but the identified risk groups are difficult to reach for a pharmacy-based testing service. More studies are needed to identify suitable target groups, including customers seeking sexual health services, particularly emergency contraception users who already receive counselling for STIs at community pharmacies.<\/jats:p>","DOI":"10.3390\/ijerph17249389","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T09:12:57Z","timestamp":1608023577000},"page":"9389","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Who Is Best to Test? A Systematic Review of Chlamydia Infections in Switzerland"],"prefix":"10.3390","volume":"17","author":[{"given":"Melanie","family":"Haag","sequence":"first","affiliation":[{"name":"Pharmaceutical Care Research Group, University of Basel, 4001 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Zemp","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland"},{"name":"University of Basel, 4001 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8678-697X","authenticated-orcid":false,"given":"Kurt E.","family":"Hersberger","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Research Group, University of Basel, 4001 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-4104","authenticated-orcid":false,"given":"Isabelle","family":"Arnet","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Research Group, University of Basel, 4001 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/sextrans-2019-054096","article-title":"Pharmacy-based sexual health services: A systematic review of experiences and attitudes of pharmacy users and pharmacy staff","volume":"95","author":"Gauly","year":"2019","journal-title":"Sex. Transm. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.contraception.2016.12.002","article-title":"Pharmacy provision of sexual and reproductive health commodities to young people: A systematic literature review and synthesis of the evidence","volume":"95","author":"Gonsalves","year":"2017","journal-title":"Contraception"},{"key":"ref_3","unstructured":"Public Health England (2016). National Chlamydia Screening Programme Standards, Updated November 2018."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1071\/SH11191","article-title":"Chlamydia screening in community pharmacies: A systematic literature review of the characteristics of service users and a meta-analysis of chlamydia prevalence","volume":"10","author":"Kapadia","year":"2013","journal-title":"Sex. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(02)00387-6","article-title":"Screening for Chlamydia trachomatis infection is indicated for women under 30 using emergency contraception","volume":"66","author":"Kettle","year":"2002","journal-title":"Contraception"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ijpp.12042","article-title":"Self-reported risk factors for chlamydia: A survey of pharmacy-based emergency contraception consumers","volume":"22","author":"Gudka","year":"2014","journal-title":"Int. J. Pharm. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMcp1412935","article-title":"Screening for Chlamydia trachomatis Infections in Women","volume":"376","author":"Wiesenfeld","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: Challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","unstructured":"Federal Office of Public Health (2019). HIV, Syphilis, Gonorrhea and Chlamydia in Switzerland in 2018: An epidemiological overview. BAG Bull., 41, 10\u201336."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0956462415618837","article-title":"2015 European guideline on the management of Chlamydia trachomatis infections","volume":"27","author":"Lanjouw","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/infdis\/jit094","article-title":"Spontaneous resolution of genital Chlamydia trachomatis Infection in women and protection from reinfection","volume":"207","author":"Geisler","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_12","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm. Rep."},{"key":"ref_13","first-page":"705","article-title":"Sexually transmitted infections with Chlamydia trachomatis","volume":"11","author":"Notter","year":"2017","journal-title":"Swiss Med. Forum"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1071\/SH12069","article-title":"Chlamydia screening interventions from community pharmacies: A systematic review","volume":"10","author":"Gudka","year":"2013","journal-title":"Sex. Health"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Arnet, I., Gudka, S., Salter, S., Hersberger, K.E., and Clifford, R. (2018). Readiness of pharmacists and consumers for pharmacy-based chlamydia screening in Australia and Switzerland. Sex. Reprod. Healthc.","DOI":"10.1016\/j.srhc.2018.03.006"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"ref_17","first-page":"w13126","article-title":"Chlamydia trachomatis infection in a Swiss prison: A cross sectional study","volume":"140","author":"Steiner","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"ref_18","unstructured":"National Heart Lung and Blood Institute (2020, August 02). Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies, Available online: https:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/in-develop\/cardiovascular-risk-reduction\/tools\/cohort."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s11606-018-4658-5","article-title":"Hospitalized Patients\u2032 Knowledge of Care: A Systematic Review","volume":"33","author":"Sommer","year":"2018","journal-title":"J. Gen. Intern. Med."},{"key":"ref_20","unstructured":"RStudio Team (2016). RStudio: Integrated Development for R, RStudio, Inc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3201\/eid1709.100865","article-title":"Role of Chlamydia trachomatis in Miscarriage","volume":"17","author":"Baud","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007435-200211000-00016","article-title":"Swiss Sentinel Surveillance Network of Gynecologists. National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland","volume":"29","author":"Paget","year":"2002","journal-title":"Sex. Transm. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Baud, D., Jaton, K., Bertelli, C., Kulling, J.P., and Greub, G. (2008). Low prevalence of Chlamydia trachomatis infection in asymptomatic young Swiss men. BMC Infect. Dis., 8.","DOI":"10.1186\/1471-2334-8-45"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Haller, D.M., Steiner, A.S., Sebo, P., Gaspoz, J.M., and Wolff, H. (2011). Chlamydia trachomatis infection in males in a juvenile detention facility in Switzerland. Swiss Med. Wkly., 141.","DOI":"10.4414\/smw.2011.13220"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10903-010-9354-4","article-title":"Prevalence and associated factors for Chlamydia trachomatis infection among undocumented immigrants in a primary care facility in Geneva, Switzerland: A cross-sectional study","volume":"12","author":"Jackson","year":"2010","journal-title":"J. Immigr. Minor. Health"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wolff, H., Louren\u00e7o, A., Bodenmann, P., Epiney, M., Uny, M., Andreoli, N., Irion, O., Gaspoz, J.M., and Dubuisson, J.B. (2008). Chlamydia trachomatis prevalence in undocumented migrants undergoing voluntary termination of pregnancy: A prospective cohort study. BMC Public Health, 8.","DOI":"10.1186\/1471-2458-8-391"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bally, F., Quach, A., Greub, G., Jaton, K., Petignat, C., Ambord, C., Fellay, J., Masserey, E., and Spencer, B. (2015). Opportunistic testing for urogenital infection with Chlamydia trachomatis in south-western Switzerland, 2012: A feasibility study. Eurosurveillance, 20.","DOI":"10.2807\/1560-7917.ES2015.20.9.21051"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/644740","article-title":"High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland","volume":"49","author":"Dang","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Redmond, S.M., Alexander-Kisslig, K., Woodhall, S.C., van den Broek, I.V., van Bergen, J., Ward, H., Uuskula, A., Herrmann, B., Andersen, B., and Gotz, H.M. (2015). Genital chlamydia prevalence in Europe and non-European high income countries: Systematic review and meta-analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0115753"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1017\/S0950268812002567","article-title":"Testing for Chlamydia trachomatis: Time trends in positivity rates in the canton of Basel-Stadt, Switzerland","volume":"141","author":"Schmutz","year":"2013","journal-title":"Epidemiol. Infect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13625187.2019.1661377","article-title":"Do Swiss community pharmacists address the risk of sexually transmitted infections during a consultation on emergency contraception? A simulated patient study","volume":"24","author":"Haag","year":"2019","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"ref_32","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014","volume":"63","author":"Papp","year":"2014","journal-title":"MMWR Recomm. Rep."},{"key":"ref_33","unstructured":"Centers for Disease Control and Prevention (CDC) (2002). Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections\u20142002. MMWR, 51, 1\u201339."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Huai, P., Li, F., Chu, T., Liu, D., Liu, J., and Zhang, F. (2020). Prevalence of genital Chlamydia trachomatis infection in the general population: A meta-analysis. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05307-w"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(18)31816-6","article-title":"Population effectiveness of opportunistic chlamydia testing in primary care in Australia: A cluster-randomised controlled trial","volume":"392","author":"Hocking","year":"2018","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/01.OLQ.0000130535.96576.D3","article-title":"Chlamydia and Gonorrhea Co-occurrence in a High School Population","volume":"31","author":"Nsuami","year":"2004","journal-title":"Sex. Transm. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3855\/jidc.10020","article-title":"Who should be screened for Chlamydia trachomatis infection? Three years\u2019 experience at a University Hospital in Switzerland","volume":"12","author":"Catarino","year":"2018","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_38","unstructured":"Centre for Evidence-Based Medicine (CEBM) (2019, July 23). Oxford Centre for Evidence-Based Medicin-Levels of Evidence. Available online: https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/."},{"key":"ref_39","unstructured":"Council of Europe (2020, March 20). Resolution CM\/Res(2020)3 on the Implementation of Pharmaceutical Care for the Benefit of Parients and Health Services. Available online: https:\/\/search.coe.int\/cm\/pages\/result_details.aspx?objectid=09000016809cdf26."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/24\/9389\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:16Z","timestamp":1760179516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/24\/9389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":39,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijerph17249389"],"URL":"https:\/\/doi.org\/10.3390\/ijerph17249389","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}